Literature DB >> 123929

The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

R I Lehrer.   

Abstract

We tested the ability of human peripheral blood monocytes to kill Candida albicans and Candida parapsilosis. Evidence that multiple fungicidal mechanisms operate in normla monocytes was found. Normal monocytes ingested and killed viable C. albicans, and could iodinate heat-killed C. albicans. Both functions were defective in monocytes from subjects with myeloperoxidase deficiency or chronic granulomatous disease. Methimazole, isoniazid, and aminotriazole inhibited iodination by normal monocytes without impairing their ability to kill C. albicans, indicating that iodination was not essential to the myeloperoxidase-hydrogen peroxide-mediated fungicidal system of the monocyte. C. parapsilosis, an organism killed with supranormal efficacy by monocytes from a patient with hereditary myeloperoxidase deficiency, was selected to examine the myeloperoxidase-independent fungicidal mechanisms of monocytes. Monocytes were obtained from the blood of normal or leukemic subjects and homogenized in 0.34 M sucrose to yield fractions rich in cytoplasmic granules. These fractions were extracted with 0.01 M citric acid and the soluble components were separated by micropreparative polyacrylamide electrophoresis. Monocytes were found to contain cationic proteins, other than myeloperoxidase, that kill C. parapsilosis in vitro.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 123929      PMCID: PMC301752          DOI: 10.1172/JCI107937

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Disk electrophoresis of basic proteins and peptides on polyacrylamide gels.

Authors:  R A REISFELD; U J LEWIS; D E WILLIAMS
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

4.  Phagocytosis by human monocytes.

Authors:  M J Cline; R I Lehrer
Journal:  Blood       Date:  1968-09       Impact factor: 22.113

5.  Peroxidatic activity in resident peritoneal macrophages and exudate monocytes of the guinea pig after ingestion of latex particles.

Authors:  W T Daems; R E Poelman; P Brederoo; E J van Lohuzen
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

6.  Defective bactericidal activity of monocytes in fatal granulomatous disease.

Authors:  G E Rodey; B H Park; D B Windhorst; R A Good
Journal:  Blood       Date:  1969-06       Impact factor: 22.113

7.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

8.  Phagocytic and bacterial properties of normal human monocytes.

Authors:  R T Steigbigel; L H Lambert; J S Remington
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

9.  Mononuclear phagocytes (Kupffer cells) and endothelial cells. Identification of two functional cell types in rat liver sinusoids by endogenous peroxidase activity.

Authors:  J J Widmann; R S Cotran; H D Fahimi
Journal:  J Cell Biol       Date:  1972-01       Impact factor: 10.539

10.  Differentiation of monocytes. Origin, nature, and fate of their azurophil granules.

Authors:  B A Nichols; D F Bainton; M G Farquhar
Journal:  J Cell Biol       Date:  1971-08       Impact factor: 10.539

View more
  43 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

2.  Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease.

Authors:  M Fujita; E Harada; T Matsumoto; Y Mizuta; S Ikegame; H Ouchi; I Inoshima; S Yoshida; K Watanabe; Y Nakanishi
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

3.  Effect of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver.

Authors:  R T Sawyer; R E Garner; J A Hudson
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease.

Authors:  Hideko Kajiwara; Mitsumasa Saito; Shouichi Ohga; Takeshi Uenotsuchi; Shin-ichi Yoshida
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  Fungicidal activity of human neutrophils and monocytes on dermatophyte fungi, Trichophyton quinckeanum and Trichophyton rubrum.

Authors:  R A Calderon; R J Hay
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

6.  Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages.

Authors:  E M Peterson; R A Calderone
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

7.  Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro.

Authors:  R D Diamond; R A Clark
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

8.  Impaired monocyte-mediated cytotoxicity in atopic dermatitis.

Authors:  K Kragballe; T Herlin; J R Jensen
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

9.  Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.

Authors:  N P Cummings; M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro.

Authors:  R D Diamond; C C Haudenschild
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.